Why not get #BoostedByTheBells at the newly re-opened EICC?
It is available for drop-in’s and pre-booked appointments. Prefer to make an appointment? We have available slots across many of our venues.
Visit NHS Inform to find out more: http://ow.ly/Sg4J50Hgjvp
The Prime Minister has today set out the government’s plan to manage Covid throughout autumn and winter.
Thanks to the ‘phenomenal success’ of the vaccination programme, the data continues to show the link between cases, hospitalisations and deaths has weakened significantly.
In England, the number of hospital admissions with Covid has remained relatively stable over the last month.
And although deaths increased at the beginning of the summer, they have remained far below the levels in either of the previous waves.
Over autumn and winter, the government will aim to sustain this progress through:
Vaccines will continue to be our first line of defence. All those who were vaccinated during Phase 1 of the vaccine programme (priority groups 1 to 9) will be offered booster jabs from this month – to boost immunity amongst the most vulnerable groups during winter.
The Test, Trace and Isolate programme will continue its important work, with symptomatic PCR testing continuing throughout the autumn and winter.
Lateral flow tests will also remain free of charge but at a later stage, as our response to the virus changes, this will end and individuals and businesses will be expected to bear the cost. The government will engage widely on this before any changes are made.
The legal obligation to self-isolate for those who have tested positive and their unvaccinated contacts will continue, and the financial support payment for those self-isolating on certain benefits will continue in its current format until the end of March.
Our NHS will continue to get the support it needs, with an extra £5.4 billion recently announced for the next 6 months alone for the Covid response.
The public will be offered continued guidance on how to protect themselves and each other – including letting fresh air in, wearing a face covering in crowded and enclosed place where you come into contact with people you don’t normally meet, getting testing and self-isolating if required.
Our tough border policy will remain in place and genomic sequencing capability will be increased to help scientists update our vaccines to defeat new variants.
As the PM also set out, autumn and winter could pose renewed challenges and it is difficult to predict the path of the virus with certainty.
So as the public would expect, there will be a range of ‘Plan B’ measures kept under review to help control transmission of the virus while minimising economic and social damage.
Plan B would include:
The government could also consider asking people to work from home again if necessary, but a final decision on this would be made at the time, dependent on the latest data – recognising the extra disruption this causes to individuals and businesses.
Ministers would only decide to implement these measures if necessary, and if a range of metrics and indicators mean the NHS is at risk of becoming overwhelmed.
Plan B recognises the success of our vaccination programme – meaning smaller interventions which are far less disruptive can have a much bigger impact on reducing the spread.
The Prime Minister committed to taking whatever action is necessary to protect the NHS, but stressed his belief that the combined efforts of the public and the vaccination programme mean we can avoid plan B and protect our freedoms in the coming months.
Good afternoon everybody.
I want to set out our plan for managing Covid this autumn and winter.
And I want you to cast your mind back exactly a year and think where we were last September, as schools went back and the colder months approached.
Because in one way our position today is actually more challenging.
We have higher levels of daily cases – thousands more.
But in many other crucial respects, the British people – all of us collectively and individually – are incomparably better placed to fight the disease.
We have more than 80 per cent of all over-16s now double jabbed, double vaccinated.
And we have Covid antibodies in around 90 per cent of the adult population.
And those vaccines are working.
We have seen the extraordinary vaccine-induced falls in deaths and serious disease.
And depending on your age, you’re up to nine times more likely to die, sadly, if you’re unvaccinated, than if you’ve had both jabs.
And the result of this vaccination campaign is that we have one of the most free societies and one of the most open economies in Europe.
And that’s why we are now sticking with our strategy.
In essence, we’re going to keep going.
We will continue to offer testing.
We will continue to urge everyone to be sensible, to be responsible.
Wash your hands.
Use ventilation.
Consider wearing a face covering in crowded places with people that you don’t know.
Stay at home if you feel unwell.
Download and use the app.
And we’re investing massively in our NHS to meet the pressures of Covid with an additional £5.4 billion in England over the next six months.
And that’s on top of almost £36 billion over the next three years to help our NHS recover and fix the long-standing problems of social care as well, as I was saying last week.
And we are helping to vaccinate the world with 100 million doses for developing countries by next June.
And I think this country should be proud, continue to be very proud, that the Oxford-AstraZeneca vaccine remains the workhorse of global immunisation.
And we will keep further measures in reserve – a Plan B.
We do not see the need now to proceed for instance with mandatory certification.
But we will continue to work with the many businesses that are getting ready for such a scheme.
indeed over 200 events have already used Covid certification voluntarily.
And it is just not sensible to rule out completely this kind of option now when we must face the fact that it might still make the difference between keeping businesses open at full capacity or not.
We will also keep open the option of mandating face coverings as they have elsewhere, or advising people again to work from home, reflecting the fact that when you’ve got a large proportion of the country as we have now with immunity, then smaller changes can make a bigger difference and give us the confidence that we don’t need to go back to the lockdowns of the past.
And of course, we will continue to update our advice to you based on the latest data.
But in the meantime, we are confident in the vaccines that have made such a difference to our lives.
And we are now intensifying that effort, offering jabs to 12 to 15 year olds on the advice of the Chief Medical Officers, who’ve given that advice based on the health, wellbeing and educational prospects of the children themselves.
And for over 50s – and the under 50s who are at risk, or more at risk, we’re now motoring ahead with the booster programme.
A third dose six months after your second dose.
So that’s going to mean we’re going to be building even higher walls of immunisation of vaccine protection in this country.
And the UK government has procured at scale jabs for every part of the UK.
And we will be sending doses to the Devolved Administrations in Scotland, Wales and Northern Ireland.
Covid is still out there.
The disease sadly still remains a risk.
But I’m confident we can keep going with our plan to turn jabs jabs jabs into jobs jobs jobs.
And protect the gains that we have made together.
Millions of people most vulnerable to COVID-19 may be offered a booster vaccination from September to ensure the protection they have from first and second doses is maintained ahead of the winter and against new variants, following interim advice from the Joint Committee on Vaccination and Immunisation (JCVI).
The JCVI’s interim advice is to plan to offer COVID-19 booster vaccines from September 2021, in order to prolong the protection that vaccines provide in those who are most vulnerable to serious COVID-19 ahead of the winter months.
The 2-stage programme would take place alongside the annual flu vaccination programme. Further details of the flu vaccination programme will be set out in due course.
The final JCVI advice will be published before September and will take into account the latest epidemiological situation, additional scientific data from trials such as Cov-Boost, real-time surveillance of the effectiveness of the vaccines over time and emerging variants. The final advice could change from the interim advice as further data is analysed.
The government is working closely with the NHS to ensure that if a booster programme happens it can be deployed rapidly from September. Further details will be set out in due course.
Health and Social Care Secretary, Sajid Javid said: “The phenomenal vaccine rollout has already saved tens of thousands of lives and prevented millions of infections, helping to wrestle back control of the pandemic and ease lockdown restrictions so we can return to normal as soon as possible.
“We welcome this interim advice, which will help us ensure we are ready in our preparations for autumn. We look forward to receiving the committee’s final advice in due course.
“We need to learn to live with this virus. Our first COVID-19 vaccination programme is restoring freedom in this country, and our booster programme will protect this freedom. We are working with the NHS to make sure we can rapidly deliver this programme to maintain protection for people in the winter months.”
Dependent on final advice, the booster programme will be designed to protect as many vulnerable people as possible from becoming seriously ill due to COVID-19 over the winter period.
COVID-19 vaccines provide very strong protection against serious illness. There is good evidence that 2 doses of any COVID-19 vaccine used in the UK will provide strong protection against severe disease for at least 6 months for the majority, and there is some evidence that longer lasting protection may be afforded to some.
As is common with flu, winter will lead to rising cases and further pressure on the NHS. The JCVI’s interim position on booster vaccinations is to ensure the protection that has been built up in the population does not decline through the winter months, and that immunity is maximised to provide additional resilience against variants.
As most younger adults will receive their second COVID-19 vaccine dose in late summer, the benefits of booster vaccination in this group will be considered by the JCVI at a later time when more information is available.
Vaccines minister, Nadhim Zahawi said: “Our COVID-19 vaccination programme has been a roaring success, with almost 85% of adults across the UK receiving a first dose and more than 62% getting both doses.
“We are now planning ahead to future-proof this progress and protect our most vulnerable from variants and flu ahead of the winter.
“Vaccines are the best way to stay on top of this virus and I urge everybody to take up the offer as soon as possible.”
The JCVI’s interim advice is that a third booster jab is offered to the following groups in 2 stages:
Stage 1. The following people should be offered a third dose COVID-19 booster vaccine and the annual influenza vaccine as soon as possible from September 2021:
Stage 2. The following people should be offered a third COVID-19 booster vaccine as soon as practicable after stage 1 with equal emphasis on deployment of the influenza vaccine where eligible:
Deputy Chief Medical Officer for England, Professor Jonathan Van-Tam said: “Where the UK has reached so far on vaccination is truly fantastic. But we need to keep going and finish giving second doses to those remaining adults who have not had them; this is the best thing we can do prevent the disease from making a comeback which disrupts society later in the year.
“Being able to manage COVID-19 with fewer or no restrictions is now heavily dependent on the continued success of the vaccination programme. We want to be on the front foot for COVID-19 booster vaccination to keep the probability of loss of vaccine protection due to waning immunity or variants as low as possible. Especially over the coming autumn and winter.
“Fewer or no restrictions will mean that other respiratory viruses, particularly flu, will make a comeback and quite possibly be an additional problem this winter, so we will need to ensure protection against flu as well as maintaining protection against COVID-19.
“The announcement of interim advice from JCVI is good news. It shows that the vaccine experts are thinking carefully about how best to use vaccination to protect the most vulnerable and ensure everyone’s lives can remain as normal as possible for the autumn and winter.
“Of course we have to be driven by data, and there will be more data from vaccine booster studies for JCVI to look at over summer, so we should all remember that this advice is interim and might change between now and September. However JCVI has clearly set out the broad direction of travel which I agree with, and which ministers have accepted.”
The success of the vaccination programme is weakening the link between cases and hospitalisations. The latest analysis from Public Health England (PHE) and the University of Cambridge suggests that vaccines have so far prevented an estimated 7.2 million infections and 27,000 deaths in England alone.
The government met its target of offering a vaccine to the most vulnerable by 15 April and is on track to offer a first dose to all adults by 19 July, 2 weeks earlier than planned.
Everyone over the age of 18 and over is eligible to get a vaccine. By 19 July, all those aged 40 and over and the clinically extremely vulnerable, who received their first dose by mid-May, will have been offered their second dose.
Data from Public Health England (PHE) shows that COVID-19 vaccines are highly effective against hospitalisation from the Delta (B.1.617.2) variant. The analysis suggests the Pfizer/BioNTech vaccine is 96% effective and the Oxford/AstraZeneca vaccine is 92% effective against hospitalisation after 2 doses.
YouGov polling also shows the UK continues to top the list of nations where people are willing to have a COVID-19 vaccine or have already been vaccinated and ONS data published on 9 June shows that more than 9 in 10 (94%) adults reported positive sentiment towards the vaccine.
See JCVI’s interim advice on potential coronavirus (COVID-19) booster vaccine programme.
